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Abstract  21 
Campylobacter jejuni is a commensal bacterium in the intestines of animals and 22 
birds and a major cause of foodborne gastroenteritis in humans worldwide. Here we 23 
show that exposure to pancreatic amylase leads to secretion of an α-dextran by C. 24 
jejuni and that a secreted protease, Cj0511, is required. Exposure of C. jejuni to 25 
pancreatic amylase promotes biofilm formation in vitro, increases interaction with 26 
human epithelial cell lines, increases virulence in the Galleria mellonella infection 27 
model and promotes colonisation of the chicken ileum. We also show that exposure 28 
to pancreatic amylase protects C. jejuni from stress conditions in vitro suggesting 29 
that the induced α-dextran may be important during transmission between hosts. 30 
This is the first evidence that pancreatic amylase functions as an inter-kingdom 31 
signal in an enteric micro-organism.  32 
   33 
Introduction  34 
Campylobacter infection is a major cause of foodborne gastroenteritis in humans 35 
worldwide (1). Disease ranges from mild, non-inflammatory, self-limiting diarrhea to 36 
prolonged, inflammatory diarrhea and occasional serious complications such as 37 
Guillain-Barré syndrome and reactive arthritis (1). Ninety percent of human disease 38 
is attributed to C. jejuni, while Campylobacter coli accounts for the remainder (2).  39 
 In contrast to human infection, C. jejuni establishes a largely asymptomatic 40 
but persistent infection in animals and birds, and the major risk of human infection is 41 
from handling and consumption of poultry meat (3, 4, 5). Campylobacters primarily 42 
inhabit the lower gastrointestinal (GI) tract of poultry and contamination of the flesh 43 
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of the bird occurs at slaughter. Campylobacter spp. are present in the luminal crypts 44 
of the chicken gut as densely-packed communities surrounded by mucus (6), an 45 
arrangement suggestive of a biofilm, a structured community of bacteria enclosed in 46 
a self-produced exopolymeric matrix (EPM) composed primarily of polysaccharides 47 
(7). Biofilms have also been described on experimentally-infected human ileum ex 48 
vivo suggesting that this mode of growth is also important during human infection (8, 49 
9). 50 
 Despite several studies of C. jejuni biofilms (10-15), the EPM has not been 51 
characterised. Polysaccharide is a major component of most bacterial EPMs and 52 
provides the structural framework (7, 16, 17). C. jejuni produces several surface-53 
associated carbohydrate structures including lipooligosaccharide (LOS), capsular 54 
polysaccharide (CPS) and both N- and O-linked glycoproteins (18), but there is no 55 
evidence that these glycans contribute to biofilm formation (11, 19).  56 
 Enteric bacteria use environmental signals present in host environments to 57 
regulate the expression of components required for interaction with the host and 58 
signals include bile salts, mucus, low oxygen, bicarbonate and neuroendocrine 59 
stress hormones (20-22). C. jejuni shows increased interaction with intestinal 60 
epithelial cells (IECs) in response to low oxygen, bile salts and noradrenaline (23-61 
25). In addition, bile salts have recently been reported to enhance C. jejuni biofilm 62 
formation by causing release of extracellular DNA (26). 63 
 Here we show that C. jejuni responds to the presence of pancreatic amylase 64 
by secreting an α-dextran that is a component of the biofilm EPM. This is the first 65 
definitive characterisation of the polysaccharide component of C. jejuni biofilms.  66 
Importantly, pre-exposure to pancreatic amylase results in significant changes in the 67 
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interactions of C. jejuni with the host in both in-vitro and in-vivo infection models. 68 
Pre-exposure to pancreatic amylase also promotes stress tolerance in vitro 69 
suggesting that the α-dextran may be important during transmission. This is the first 70 
evidence that pancreatic amylase is used by an enteric micro-organism as a signal 71 
to regulate interaction with the host.  72 
 73 
MATERIALS AND METHODS 74 
Bacterial strains and growth conditions. Bacterial strains are listed in Table 1. C. 75 
jejuni was stored at -70ºC in Brucella broth (BB; Oxoid) containing 15% glycerol and 76 
was grown on Mueller Hinton agar (MHA; Oxoid), Brucella agar (BA; Oxoid), 77 
Columbia blood agar (CBA; Oxoid) containing 7% defibrinated horse blood (E & O 78 
Laboratories) in a microaerobic atmosphere generated using Campypaks (Oxoid) in 79 
gas jars at 37°C. Charcoal (0.4%) was added to BA to improve contrast for 80 
photography. For broth cultures, BB or Eagle’s Minimal Essential Medium-α (MEM-81 
α; Sigma-Aldrich, M0894) were used and incubated with shaking (50 rpm) at 37°C in 82 
5% CO2. Kanamycin (Km; 40 μg/ml) and chloramphenicol (Cm; 20 μg/ml) were used 83 
for selection.  84 
 85 
Sources of pancreatic amylase. Hog pancreatic α-amylase (HPA) was purchased 86 
from Sigma Aldrich. Polyhistidine-tagged human pancreatic amylase expressed and 87 
purified from human cells was obtained from Sino Biologicals. For chicken pancreas 88 
extract, 20 organs were homogenized in 0.05 M Tris, 0.9% NaCl, 0.05 M CaCl2, pH 89 
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8.0 (27). After centrifugation (1,000 x g, 20 min), amylase activity in the supernatant 90 
was quantified by enzymatic assay (28).  91 
 92 
EPM purification and characterisation. Growth (48 h) removed from MHA with or 93 
without 100 nM HPA was suspended in phosphate buffered saline (PBS) and the 94 
extracellular material was recovered using modifications of a method previously used 95 
to isolate exo-polysaccharide from Vibrio parahaemolyticus (29). Briefly, the bacterial 96 
cell suspensions in PBS were washed on a rotary platform at 200 rpm for 1.5 h at 97 
30ºC, vortexed for 15 min and washed again at 200 rpm for 1.5 h at 20ºC. The 98 
supernatant was recovered (1,800 x g, 15 min) and precipitated overnight with 4 99 
volumes of cold acetone at 4°C. The precipitate was recovered (450 x g, 5 min), 100 
washed in distilled water (dH2O), dried (Speedvac SPD1010, Thermo Scientific), 101 
dissolved in dH2O and stored at -70°C. Total carbohydrate was measured by phenol-102 
sulphuric acid assay (30) with glucose as standard and statistical significance was 103 
assessed using a two-sample t-test. Further characterisation of the EPM 104 
carbohydrate was performed after dialysis (14 kDa MWCO) for 72 h at 4oC against 105 
three changes of dH2O per day. The EPM was freeze dried and characterized using 106 
NMR spectroscopy (31), monomer analysis (32) and linkage analysis (33) in 107 
comparison with a commercial α-dextran standard (Sigma-Aldrich).  108 
 109 
Genetic complementation of a cj0511 mutant. A cj0511 mutant obtained from a 110 
collection at the London School of Hygiene and Tropical Medicine (Table 1) was 111 
used to construct a complemented strain by insertion of cj0511 under the control of 112 
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the iron-inducible fdxA promoter into a pseudogene (cj0046) in the cj0511 mutant as 113 
previously described (34). The oligonucleotides used are listed in Table 2. 114 
 115 
Production of recombinant Cj0511 and proteolysis assay 116 
Codon optimized cj0511 was synthesized by Celtek, USA and obtained in pGH. The 117 
gene was cut by HindIII (New England Biolabs, UK) and the released DNA fragment 118 
was cloned in pET-28a(+)(Novagen, UK) to generate pMAR31. Expression of cj0511 119 
was achieved in E.coli BL21 (DE3) (New England Biolabs, UK). To localize the 120 
recombinant protein in the periplasm of E.coli, recombinant Cj0511 was modified to 121 
have a signal peptide from the E.coli DsbA protein fused to the N-terminal, while the 122 
C-terminus was fused to a 6 x-His affinity tag. Recombinant Cj0511 was purified 123 
using nickel affinity column (Qiagen) and eluted in 500 mM imidazole, 300 mM 124 
sodium phosphate and 20 mM sodium chloride buffer. The eluted fractions were 125 
combined and concentrated using an Amicon ultrafiltration column with a 100 kDa 126 
cut off (Merck Millipore, UK) then resuspended in 10 mM sodium phosphate buffer. 127 
One microgram of purified r-Cj0511 was mixed with 2 μg polyhistidine-tagged human 128 
pancreatic amylase (Sino Biologicals) or casein (Sigma Aldrich) in 20 μL of 50 mM 129 
sodium phosphate buffer (pH 7.5) and incubated at 37°C for a total of 2 h. The 130 
reactions were stopped using 6 x Laemmli buffer and the reaction mixtures were 131 
boiled for 10 min before being separated by SDS-PAGE (16% polyacrylamide) and 132 
stained with Coomassie R-250.   133 
 134 
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Biofilm assays. A 16 h culture of C. jejuni in BB was diluted to OD600 of 0.1 in BB 135 
with or without 100 nM HPA, 100 nM recombinant human pancreatic amylase or an 136 
equivalent activity of chicken pancreas extract, added to a borosilicate glass tube 137 
(VWR International) and incubated without shaking at 37°C in 5% CO2. After 48 h 138 
the culture was decanted, the biofilms were washed with dH2O, dried and stained for 139 
5 min with 0.1% (w/v) crystal violet (CV; Sigma-Aldrich), washed with dH2O and 140 
dried. Bound CV was solubilised in 80% ethanol-20% acetone and quantified by 141 
measuring OD600. Statistical significance was assessed with a two-sample t-test 142 
assuming unequal variance.  143 
 144 
Confocal laser scanning microscopy of biofilm. A 16 h culture of C. jejuni was 145 
diluted to OD600 of 0.1 in BB with or without 100 nM HPA and placed in a 6-well 146 
tissue culture plate (Sarstedt). Two glass coverslips were placed upright in each well 147 
and incubated for 48 h at 37°C in 5% CO2. The coverslips were washed in PBS, 148 
stained with Live/Dead BacLight stain (Invitrogen) according to the manufacturer’s 149 
instructions and visualised with a BioRad Radiance 2100 confocal scanning system 150 
attached to an Olympus BX51 upright microscope. Digital images were produced 151 
using Image J software (National Institutes of Health). 152 
   153 
Adhesion and invasion of Caco-2 cells. Human colon cancer cells (Caco-2) were 154 
cultured as previously described (25) and 108 bacteria, grown on MHA with or 155 
without 100 nM HPA, were added at a multiplicity of infection (MOI) of 100:1 and 156 
incubated at 37°C in 5% CO2. Interacting and invading bacteria were enumerated at 157 
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3, 6 and 24 h as previously described (25) and statistical significance was assessed 158 
using a two-sample t-test assuming unequal variance. 159 
 160 
Interaction with T84 human colonic epithelial cells. T84 cells were grown in 161 
complete Dulbecco’s Modified Eagle’s Medium Nutrient Mixture F-12 HAM 162 
(Invitrogen) in rat collagen pre-coated transwell dishes until the transepithelial 163 
electrical resistance (TEER) measurement (35) was >800 Ω confirming formation of 164 
tight-junctions in the monolayer. Co-culture studies were performed at a MOI of 10:1 165 
in DMEM/F12 HAM medium containing 10% foetal bovine serum for 6 or 24 h. 166 
Bacteria were grown on MHA with or without 100 nM HPA and viable counts were 167 
performed. Statistical significance was assessed using a Wilcoxon matched paired 168 
test. IL-8 levels were determined by ELISA (eBioscience) from the supernatant of the 169 
apical surface at 24 h post-infection.  170 
 171 
Galleria mellonella infection model. G. mellonella larvae were obtained 172 
commercially (Cornish Crispa Co) and stored in containers with wood chips at 12°C. 173 
C. jejuni strains were grown on MHA with or without 100 nM HPA for 48 h, harvested 174 
in PBS and 106 cfu injected into the right foreleg of 10 Galleria larvae as previously 175 
described (36). Statistical significance was assessed using a two-sample t-test, 176 
assuming unequal variance. 177 
 178 
Infection of chickens. Day-old Ross broiler chickens were obtained from a 179 
commercial supplier and housed in biosecure housing. The study was performed 180 
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under a project licence issued by the UK Home Office under the Animals (Scientific 181 
Procedures) Act 1986 (PPL 30/2599) and protocols and euthanasia techniques were 182 
approved by the University of Bristol Animal Welfare Ethical Review Board. Birds 183 
were fed commercial starter and grower diets (BOCM Pauls Ltd, Ipswich), had 184 
access to food and water ad libitum and were exposed to a 12 h light/darkness cycle. 185 
At 21 days old, groups of 30 birds were infected by oral gavage with 105 of C. jejuni 186 
11168H or the cj0511 mutant grown on MHA with or without 100 μM HPA for 48 h 187 
and resuspended in MH broth. Fifteen birds were euthanized by cervical dislocation 188 
at 4 and 7 days post infection and ileum and liver samples removed for culture. Ileum 189 
samples were serially diluted and plated on modified charcoal cefoperazone 190 
deoxycholate agar (mCCDA; Oxoid) incubated at 37oC for 48 h in microaerobic 191 
conditions. Liver samples were homogenised and enriched in modified Exeter broth 192 
(37), incubated with minimal headspace at 37oC for 48 h and plated on mCCDA.  193 
Differences in the number of birds colonised were assessed using a Chi-square test. 194 
Differences in the number of bacteria found at each site were analysed using a 195 
Kruskal-Wallis test with Dunn’s multiple comparison test.  196 
 197 
Resistance to environmental stress. The growth from 48 h MHA plates with and 198 
without 100 nM HPA was recovered into PBS (4°C) or MH broth (20°C), washed and 199 
resuspended to an OD600 of 2.0. The cultures were incubated with shaking (50 rpm) 200 
at 37°C in 5% CO2 and samples were removed at intervals for viable counting.  The 201 
statistical significance of the difference in viable counts in the presence and absence 202 
of HPA was assessed using two sample t-tests, assuming unequal variance.   203 
 204 
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RESULTS 205 
C. jejuni responds to the presence of pancreatic amylase. Physiological 206 
concentrations of mammalian pancreatic α-amylase are estimated to be nanomolar 207 
(38). When hog pancreatic α-amylase (HPA) was incorporated into agar at various 208 
concentrations, we observed the formation of large mucoid colonies of C. jejuni 209 
11168H at a minimum concentration of 100 μM (Fig. 1A). It is important to note that 210 
mucoid colonies were apparent on MHA and also on BA containing 100 μM HPA; 211 
since BA does not contain starch, this indicates that the response is independent of 212 
amylase starch degrading activity. Whilst 100 μM pancreatic amylase seem high 213 
compared to the estimated in vivo concentrations, it is noteworthy that the number of 214 
molecules of amylase that can interact with the bacteria growing on an agar plate is 215 
likely to be low because of spatial confinement, in contrast to physiological 216 
conditions where bacteria will be bathed in litres of pancreatic juice per day.  Mucoid 217 
colonies were also produced by other C. jejuni strains (81-176, 81116, G1, X) in 218 
response to 100 μM HPA but not by the periodontal pathogen, Campylobacter rectus 219 
NCTC 11489 (data not shown).  220 
Pancreatic amylase promotes C. jejuni growth. As the colonies on amylase were 221 
larger in addition to being mucoid, the number of bacteria per colony was determined 222 
for C. jejuni 11168H from HPA-containing (100 μM) and amylase-free MHA. In three 223 
experiments, colonies contained a mean of 5.3 (+/-3.2) x 107 cfu in the presence of 224 
amylase, compared to 3.3 (+/-2.3) x 106 cfu in the absence of amylase, representing 225 
a 16-fold increase. In MEM-α, supplementation with physiological concentrations 226 
(100 nM) of HPA resulted in an increased growth rate (mean generation time of 180 227 
(+/-0) minutes in the presence of pancreatic amylase compared to 280 (+/-35) 228 
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minutes in its absence). The difference in growth rate was statistically significant 229 
(p<0.001) at both mid-exponential phase (10 h) and stationary phase (15 h) (Fig. 230 
1B).  231 
 232 
Mucoid colonies secrete increased amounts of carbohydrate. As mucoid 233 
colonies are suggestive of exo-polysaccharide production, we attempted to purify the 234 
extracellular material from colonies of strain 11168H grown in the presence of 235 
increasing concentrations of HPA by washing in PBS.  Measurement of the 236 
carbohydrate content of this preparation by phenol sulphuric acid assay showed that 237 
exposure to physiological concentrations of HPA (100 nM) resulted in a 100% 238 
increase in the soluble carbohydrate secreted by C. jejuni 11168H compared to 239 
growth without HPA (Fig. 2A). A 11168H kpsM mutant, unable to export CPS (39), 240 
and 11168H waaF and waaC mutants lacking the outer and entire core 241 
oligosaccharide of LOS, respectively (40, 41), also showed increased carbohydrate 242 
secretion of comparable magnitude to the wild-type (WT) strain in the presence of 243 
HPA, indicating that the secreted carbohydrate is independent of both CPS and LOS 244 
(Fig. 2B). The amount of carbohydrate secreted by the 11168H kpsM, waaC and 245 
waaF mutants did not differ significantly from the wild-type strain in either the 246 
presence or absence of pancreatic amylase. 247 
 248 
The secreted carbohydrate is an α-dextran. The soluble extracellular material 249 
recovered from C. jejuni 11168H and the kpsM mutant provided 1H and 13C-NMR 250 
spectra identical to an α-dextran standard (Fig. 2C) and distinct from starch (Fig. 251 
S1). A series of 2D-NMR (COSY, HSQC & HMBC) were also recorded (data not 252 
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shown) to confirm the identity of the exo-polysaccharide as an α-dextran. Monomer 253 
analysis was undertaken using high performance anion exchange chromatography in 254 
combination with pulsed amperometric detection.  After acid hydrolysis, the 255 
extracellular material recovered from both C. jejuni 11168H and the kpsM mutant 256 
gave chromatographs containing a single peak which co-eluted with a glucose 257 
reference standard (Fig. S2). Monomer analysis thus confirmed that glucose was the 258 
only monosaccharide present and linkage analysis showed exclusively 1,6-glycosidic 259 
links (Fig. S3).  260 
 261 
Cj0511 is essential for the response to pancreatic amylase but does not 262 
degrade it in vitro. Since HPA improves the growth of C. jejuni, we reasoned that it 263 
could be degraded by the bacterium. As Cj0511 is a protease (42) that is known to 264 
be secreted in outer membrane vesicles (OMVs) (43) and is abundant in a C. jejuni 265 
strain that colonises chickens efficiently (44), we hypothesized that it is involved in 266 
the response to pancreatic amylase. Determination of the amount of secreted 267 
carbohydrate showed that the increased secretion seen in the WT strain in response 268 
to stimulation with HPA was absent in a cj0511 mutant (Fig. 2D). Restoration of the 269 
response to HPA in the complemented strain (Fig. 2D), shows that the defect in the 270 
cj0511 mutant is the result of inactivation of cj0511 and not due to a polar effect or 271 
spontaneous mutation elsewhere in the genome. To determine if Cj0511 degrades 272 
pancreatic amylase, recombinant Cj0511 (r-Cj0511) was incubated with recombinant 273 
human pancreatic amylase or with casein (Fig. 3). Partial and complete degradation 274 
of casein was apparent at 30 min and 2 h, respectively. In contrast, there was no 275 
apparent degradation of pancreatic amylase after 2 h.  276 
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 277 
Exposure to pancreatic amylase promotes biofilm formation. To determine if 278 
exposure to pancreatic amylase contributed to biofilm formation in C. jejuni, biofilms 279 
formed at the air/liquid interface in glass tubes in the presence or absence of 280 
physiological concentrations of pancreatic amylase (100 nM) were measured by 281 
crystal violet staining. With the exception of the cj0511 mutant, all the strains showed 282 
significant increases in biofilm formation in the presence of HPA (Fig. 4A). The 283 
magnitude of the increase in biofilm in response to HPA in the waaC, waaF and 284 
kpsM mutants was similar to the WT (2.1-2.5-fold) demonstrating that it is 285 
independent of LOS and CPS. Although we observed increased biofilm formation by 286 
the cj0511 mutant compared to the WT in the absence of HPA (p=0.003), there was 287 
no significant increase in the presence of HPA in this mutant (in contrast with the 288 
complemented strain), demonstrating that a functional Cj0511 protease is required 289 
for the response (Fig. 4A). To confirm that the increased biofilm was specifically due 290 
to pancreatic amylase, the assay was repeated in the presence of 100 nM 291 
recombinant human pancreatic amylase and an increase in biofilm density of similar 292 
magnitude (2.2-fold; p=0.001) to that obtained with the preparation of HPA was 293 
observed (Fig. 4B). Addition of a volume of chicken pancreas extract containing 294 
equivalent amylase activity also resulted in an increase in biofilm density (2.2-fold; 295 
p<0.001) (Fig. 4C).  296 
 Confocal laser scanning microscopy (CLSM) was used to visualise biofilms of 297 
C. jejuni 11168H grown in the presence or absence of HPA. In the presence of HPA 298 
there was typical biofilm structure at 48 h with adherent microcolonies of live bacteria 299 
separated by dark channels, whereas there were few adherent bacteria in the 300 
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absence of HPA (Fig. 4D).  Examination in the x-z plane showed typical three-301 
dimensional biofilm structure (of maximum height 160 μm) only in the presence of 302 
HPA. 303 
 304 
Pre-exposure to pancreatic amylase promotes interaction with human IECs. To 305 
determine if pre-exposure of C. jejuni to HPA affects the interaction with IECs, 306 
strains grown with or without 100 nM HPA were co-cultured with Caco-2 cells. C. 307 
jejuni 11168H grown in the presence of HPA showed significant increases in the 308 
number of interacting bacteria after 3, 6 and 24 h of co-culture (Fig. 5A). Growth of 309 
C. jejuni 81-176 in the presence of HPA also resulted in significant increases in 310 
interaction with Caco-2 cells (data not shown). In contrast, exposure of the C. jejuni 311 
11168H cj0511 mutant to HPA did not result in increased interaction, whereas the 312 
complemented strain did show significant increases (Fig. 5A). Pre-exposure to HPA 313 
also resulted in increased invasion by strains 11168H (Fig. 5B) and 81-176 (data not 314 
shown). There was no increase in invasion by the cj0511 mutant with pre-exposure 315 
to HPA whereas the complemented strain showed a significant increase (Fig. 5B). 316 
 To explore the effect of pre-exposure to HPA on IEC cytokine responses, we 317 
measured interleukin-8 (IL-8) secretion from T84 human colon cancer cells in 318 
response to bacteria grown with or without HPA. At 24 h, we observed a significant 319 
increase in IL-8 secretion in response to infection but growth on HPA had no effect 320 
(Fig. 5C).  A similar lack of cytokine response to HPA pre-treatment was observed in 321 
THP-1 macrophages (data not shown). The effect of infection on transepithelial 322 
electrical resistance (TEER) was also investigated. No disruption in tight-junction 323 
integrity in response to C. jejuni grown on HPA was noted 6 h post-infection (data 324 
not shown), but there was a significant increase in translocation of the bacteria pre-325 
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exposed to HPA compared to those grown without HPA (Fig. 5D), a difference no 326 
longer apparent at 24 h (data not shown). 327 
 328 
Pre-exposure to pancreatic amylase results in increased killing of Galleria 329 
mellonella larvae. C. jejuni 11168H, 81-176 and the cj0511 and kpsM mutants were 330 
grown with or without HPA, injected into ten G. mellonella larvae and the number of 331 
dead larvae determined at 24 h (Fig. 6). For both WT strains, a mean of 1 - 2 larvae 332 
were killed when the bacteria were grown without HPA compared to means of ~9 333 
when grown with HPA. The increased virulence in response to HPA was lost in the 334 
cj0511 mutant but restored in the complemented strain (Fig. 6), confirming the 335 
essential role of Cj0511 in signal detection.  336 
 337 
Pre-exposure to pancreatic amylase promotes colonisation of broiler chickens. 338 
To determine whether pre-exposure to pancreatic amylase affects the ability of C. 339 
jejuni to colonise chickens, strain 11168H and the cj0511 mutant grown with or 340 
without HPA were used to infect broiler chickens of 21 days old. At day 4, the WT 341 
strain had colonised better than the cj0511 mutant but no difference was apparent 342 
between treatments (Fig. 7A).  By day 7, exposure of the WT strain to HPA prior to 343 
infection had a significant effect (p=0.005) (Fig. 7B). Differences in the numbers of 344 
bacteria present between infection groups were seen at day 4 (p=0.0006) and day 7 345 
(p=0.03). In chickens infected with strains grown in the presence of HPA, the WT 346 
strain was present in significantly higher numbers in the ileum compared to the 347 
cj0511 mutant at days 4 and 7 (Fig. 7C, D). Growth on HPA also significantly 348 
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increased the numbers of the WT strain in the ileum at day 7 whereas there was no 349 
such increase in the cj0511 mutant (Fig. 7D).  350 
 351 
Pre-exposure to pancreatic amylase promotes survival in stress environments. 352 
To assess the role of the α-dextran in survival outside the host, we cultured C. jejuni 353 
11168H in the presence or absence of 100 nM HPA, recovered the bacteria into 354 
either broth or PBS without HPA and determined by viable counting the numbers of 355 
surviving bacteria at room temperature and at 4ºC in air.  In both stress conditions, 356 
pre-exposure to HPA prolonged survival suggesting that the α-dextran has a 357 
protective effect (Fig. 8).  358 
 359 
DISCUSSION 360 
Given that C. jejuni has been described as a “sugary bug” (45) it is somewhat 361 
surprising that until the work described herein, no definitive identification of a 362 
polysaccharide involved in biofilm formation had been made. Indeed it has been 363 
suggested that DNA is a major component of the C. jejuni biofilm matrix (26). 364 
However, when C. jejuni is freshly isolated from animal or human stools it is highly 365 
mucoid (Allan, unpublished observation), suggesting that a polysaccharide matrix is 366 
being produced. This led us to hypothesize that a host factor was responsible for 367 
inducing the polysaccharide EPM.  Such interkingdom signalling between eukaryotes 368 
and prokaryotes was first identified over a century ago (46). Over the last decade or 369 
so it has been established that interkingdom signalling between bacteria and hosts, 370 
via “hormones” is widespread (47). One of the first reports of this was the effect of 371 
adrenaline and noradrenaline on E. coli (48). There are a limited number of reports 372 
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on host cell molecules affecting biofilm formation by bacteria. For example, bile salts 373 
enhance biofilm formation by C. jejuni (26), Listeria monocytogenes (49) and Vibrio 374 
cholerae (50). In the case of Streptococcus pneumonia, a number of host factors 375 
affect biofilm formation and structure including norepinephrine (51), and 376 
extracytoplasmic ATP (52). Our work shows for the first time that avian and 377 
mammalian pancreatic amylase can act as an interkingdom signalling molecule and 378 
enhance C. jejuni growth and biofilm formation. It is important to emphasise that a 379 
mucoid colony is produced on Brucella agar in response to pancreatic amylase. This 380 
medium does not contain starch, indicating that the response is directly to the 381 
presence of amylase protein and is not dependent on amylase starch degrading 382 
activity. This was confirmed in the biofilm assay which was also carried out in 383 
medium lacking starch.  To our knowledge this is only the second example of a 384 
proteinaceous host component that can enhance bacterial biofilm formation, the first 385 
being the cytokine interleukin 1β which enhances biofilm formation by 386 
Staphylococcus aureus (53). Interestingly, C. rectus did not appear to detect 387 
pancreatic amylase suggesting that the response may be a specific adaptation to 388 
host environments. It will be interesting to investigate in future work whether the 389 
enteric and oral Campylobacter spp. are able to detect the presence of salivary 390 
amylase, given its similarity in sequence and structure to pancreatic amylase.  391 
 392 
The polysaccharide secreted by C. jejuni was definitively identified as  α-dextran and 393 
the ease with which it was removed from the bacterial cell surface, by simply 394 
washing in saline, indicates that it is a loosely-associated ‘slime polysaccharide’ as 395 
oppose to the capsular polysaccharides that are covalently attached to the cell wall 396 
(16, 54). Given that C. jejuni is capable of producing complex glycan structures (18), 397 
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the production of a simple α-dextran is intriguing. Dextrans are produced by oral 398 
streptococci and Leuconostoc spp. from sucrose using dextransucrases, cell wall-399 
anchored enzymes of the glycoside hydrolase superfamily (56). Searching the 400 
translated C. jejuni genome sequences with known dextransucrase sequences did 401 
not identify homologues, suggesting that dextran synthesis in C. jejuni occurs by a 402 
novel mechanism. The source of the glucose monomer, whether it is taken up from 403 
the environment or synthesized from amino acids, awaits experimental investigation.  404 
  405 
The fact that HPA enhances the growth of C. jejuni suggested that it may be used as 406 
a nutrient source and Cj0511, predicted as a serine protease of the C-terminal 407 
protease (CTP) family and known to be secreted in OMVs (43), seemed a likely 408 
candidate for degrading pancreatic amylase.  Our data shows that a cj0511 mutant 409 
did not display the response to HPA, a phenotype that was restored in a 410 
complemented strain, confirming the role of Cj0511 specifically. However, there was 411 
no apparent change in migration of recombinant human amylase on an SDS-PAGE 412 
gel following incubation with Cj0511 even though partial casein degradation was 413 
apparent in 30 min and complete digestion in 2 h. The recombinant amylase is 414 
tagged with 6 histidine residues at the C-terminus and C-terminal proteolysis of even 415 
a single amino acid would result in a reduction of ~1 kDa in the molecular weight of 416 
the protein which would be apparent on a 16% polyacrylamide gel. In this context, it 417 
is important to emphasise that the polyhistidine-tagged human recombinant amylase 418 
preparation was active, since we showed it induced biofilm formation in the wild-type 419 
strain. Thus, interference by the polyhistidine tag cannot explain why we fail to see 420 
cleavage by r-Cj0511 in vitro. Since Cj0511 is N-glycosylated in C. jejuni (Young et 421 
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al., 2002), an absence of glycosylation in r-Cj0511 is another plausible explanation. 422 
However, we have shown that a pglB mutant (i.e. defective for N-glycosylation; 55) 423 
still responds to pancreatic amylase (Jowiya and Allan, unpublished), which 424 
discounts this explanation also. Thus we conclude that Cj0511 does not digest 425 
pancreatic amylase, at least in vitro. Bacterial CTPs are involved in a range of 426 
physiological processes. The Escherichia coli tail-specific protease processes 427 
penicillin binding proteins and regulates cell morphology (57).  CTPs with roles in 428 
virulence have also been described: for example, CtpA of Brucella suis is required 429 
for virulence in a mouse infection model (58). A recent study by Karlyshev and co-430 
workers showed that a cj0511 mutant was severely attenuated in its ability to 431 
colonise chickens (42). Since Cj0511 does not appear to degrade pancreatic 432 
amylase, we conclude that it is involved at a later stage in the molecular mechanism. 433 
Elucidation of its precise role in the response to pancreatic amylase requires further 434 
research. 435 
  436 
Having established that pancreatic amylase induces secretion of an α-dextran, we 437 
next addressed the biological consequence. Growth on physiological concentrations 438 
of HPA resulted in increased biofilm formation in two different WT strains. Moreover, 439 
the increase in biofilm formation induced by HPA was dependent on Cj0511. Since 440 
the purity of the commercial HPA preparation is not guaranteed, we tested purified 441 
recombinant human pancreatic amylase in the biofilm assay and observed an 442 
increase in biofilm formation of similar magnitude to that induced by HPA, confirming 443 
that the response is to pancreatic amylase specifically. Biofilm formation was also 444 
increased in response to an extract of chicken pancreas suggesting that the α-445 
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dextran promotes biofilm formation in the intestines of both mammalian and avian 446 
hosts.  447 
 The study next investigated the effect of HPA exposure on the interaction of 448 
C. jejuni with IECs. Growth on HPA resulted in a significant increase in adhesion and 449 
invasion of C. jejuni in Caco-2 cells. As the neutrophil chemoattractant IL-8 has a 450 
role in the response to C. jejuni (59), we studied production by T84 cells as they are 451 
more potent cytokine responders than Caco-2 cells (60). Surprisingly, no difference 452 
in IL-8 secretion in response to bacteria grown with or without HPA was observed. 453 
Pre-exposure to HPA led to a significant increase in bacterial translocation 6 h post-454 
infection, however, without loss of tight junction integrity. Collectively, these data 455 
suggest that the α-dextran modulates early host-pathogen interactions by promoting 456 
rapid intracellular transfer while avoiding overt host inflammatory responses. It is 457 
intriguing to speculate that an α-1,6-dextran evolved as a colonisation factor since it 458 
exhibits sufficient similarity to dietary starch to be tolerated by the immune system 459 
yet is resistant to the α-1,4-glucan glucanohydrolase activity of pancreatic amylase. 460 
 In the G. mellonella infection model, growth of C. jejuni on pancreatic amylase 461 
resulted in increased virulence and this is again dependent on Cj0511. G. mellonella 462 
larvae have been used as a model to study infection by C. jejuni (36) and other 463 
enteric pathogens as they possess both humoral and cellular immune systems (61). 464 
The increased insecticidal activity of C. jejuni grown on HPA suggests that biofilm 465 
formation may contribute to resistance to these immune mechanisms. It is notable 466 
that the insecticidal activity observed for C. jejuni 11168H and 81-176 in the absence 467 
of pancreatic amylase was lower than that reported by Champion et al. (36) for these 468 
strains. We assume that the decreased virulence observed in our study is a 469 
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reflection of culture on Mueller Hinton agar as oppose to Columbia blood agar which 470 
was used by Champion et al. 471 
  472 
 In the laboratory, C. jejuni is sensitive to environmental stresses such as 473 
drying, chilling, and exposure to atmospheric oxygen yet the bacterium exhibits a 474 
remarkable ability to persist in food processing facilities and natural environments 475 
(62). We have shown that pre-exposure of C. jejuni to pancreatic amylase prolongs 476 
survival in atmospheric conditions at ambient and refrigeration temperatures. This 477 
demonstrates that the α-dextran, which will be expressed by C. jejuni expelled into 478 
the environment from a host organism, is stable and may be important for the 479 
environmental resilience of the bacterium.  480 
 In conclusion, we propose a new model in which C. jejuni uses host 481 
pancreatic amylase, encountered as it passes the pancreatic duct, as a signal for 482 
secretion of an α-dextran which promotes biofilm formation and contributes to 483 
colonisation of the mammalian and avian intestine and increases resistance to host 484 
immune functions. We have shown that Cj0511, a secreted serine protease, is 485 
required for the response to pancreatic amylase although its precise function in the 486 
response is currently unknown. The demonstration of a secreted dextran that leads 487 
to biofilm formation is an important finding that is expected to enable the design of 488 
intervention strategies to reduce the burden of C. jejuni in the food chain and 489 
ultimately to reduce the incidence of human enteric disease.  490 
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Table 1. Bacterial strains and plasmids 722 
 723 
Bacterial strain Characteristics                  Reference 
C. jejuni 11168H Hyper-motile variant of NCTC 
11168; good coloniser of 
chickens  
(63) 
 
C. jejuni 81-176 Clinical isolate from human 
diarrhoea sample 
(64) 
C. jejuni 81116 Waterborne human outbreak 
strain 
(65) 
C. jejuni X Clinical isolate from patient with 
enteritis 
(66) 
C. jejuni G1 Clinical isolate from patient with 
Guillain-Barré syndrome  
(67) 
C. jejuni 11168H kpsM::aphA3 Mutant in gene encoding ABC 
transporter involved in capsule 
assembly; no CPS expression 
(68) 
 
C. jejuni 11168H waaC::aphA3 Mutant in gene encoding 
heptosyltransferase I; 
expresses truncated LOS 
Campylobacter Resource 
Facility 
(http://crf.lshtm.ac.uk/index.htm) 
C. jejuni 11168H waaF::aphA3 Mutant in gene encoding 
heptosyltransferase II: 
expresses truncated core 
oligosaccharide 
Campylobacter Resource 
Facility 
(http://crf.lshtm.ac.uk/index.htm) 
C. jejuni 11168H cj0511::aphA3 
 
Mutant in gene encoding 
secreted carboxyl-terminal 
protease. 
Campylobacter Resource 
Facility 
(http://crf.lshtm.ac.uk/index.htm) 
11168H cj0511::aphA3 pWJ4 Complemented strain 
containing cj0511 gene and  
Camr inserted into cj0046 
This study 
C. rectus NCTC 11489 Type strain, from human 
periodontal pocket 
Public Health England culture 
collections 
33 
 
E. coli JM109 Cloning host                      Promega 
E.coli BL21 (DE3) Expression host New England Biolabs 
Plasmid   
pJMK30  pUC19 carrying C. coli Kanr  
gene aphA-3 
(69) 
 
pGEM-T-Easy Cloning vector enables TA 
cloning 
Promega 
pC46fdxA 
 
Complementation vector 
containing fdxA promoter, Camr 
selection marker. 
(34) 
 724 
  725 
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Table 2. Oligonucleotides 726 
 727 
Name Sequence (5’-3’)                  Use 
WJ10F GTCGTCTCACATGTTGAAAACAAAACG Amplification of cj0511 for cloning 
in pC46fdxA (BsmBI site 
underlined) 
WJ10R GTCGTCTCACATGTTATTGTCCTTGTTTG Amplification of cj0511 for cloning 
in pC46fdxA (BsmBI site 
underlined) 
WJ4 GTAAATTTTTGATTATCAAAATTTACATTATTTAAG Orientation of cj0511 with respect 
to PfdxA in pC46fdxA; anneals in 
PfdxA 
WJ11 GGAACACAGCAGAGCACTTG Confirmation of cj0511 
complementing strain; anneals in 
cjs03 RNA coding sequence 
located 5’ to cj0046 
WJ12 CCTGGAGAAGTATTAGATAGTAGCG Confirmation of cj0511 
complementing strain; anneals in 
cj0053c located 3’ to cj0046  
 728 
 729 
  
 
FIG. 1. Exposure to pancreatic amylase promotes growth and results in a large, 
mucoid colony. A. C. jejuni 11168H grown at 37°C for 72 h on BA containing 0.4% 
charcoal without (left) or with (right) 100 M HPA. The ruler marks 5 mm intervals. B. 
C. jejuni 11168H growth with shaking (50 rpm) in 5% CO2 at 37°C in MEM-α with 
(squares) or without (diamonds) 100 nM HPA. Data reported as means and standard 
deviations (SD) from three independent experiments. The statistical significance of 
the difference in growth in the presence and absence of HPA was assessed at two 
time points (10 and 15 h) using a two-sample t-test, assuming unequal variance; 
***p<0.001. 
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FIG. 2. Physiological concentrations of pancreatic amylase induces -dextran 
secretion in C. jejuni and the secreted protease, Cj0511 is required. (A) Total 
extracellular carbohydrate in C. jejuni 11168H grown in the presence of increasing 
concentrations of HPA. (B) Total extracellular carbohydrate in different C. jejuni 
strains grown in the presence (black bars) or absence (white bars) of 100 nM HPA. 
The kpsM, waaC and waaF mutants were created in strain 11168H. (C) 1H-NMR 
spectra of extracellular material from C. jejuni 11168H, a kpsM mutant and a 
commercial -dextran recorded in D20 at 7
oC using acetone as an internal standard 
on a Bruker Avance 400 MHz spectrometer. (D) Total extracellular carbohydrate in 
C. jejuni 11168H (black bars), a Cj0511 mutant (white bars) and a Cj0511 
complemented strain (grey bars) grown on MHA with increasing concentrations of 
A. B.
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HPA. For (a), (b) and (d), data reported as mean +/- SD from three independent 
experiments. Asterisks indicate statistically significant increases in the presence of 
HPA; ***p<0.001, **p<0.01, *p<0.05.  
 
  
Fig. 3. Proteolysis of casein and pancreatic amylase by r-Cj0511. Coomassie-
stained SDS-polyacrylamide gel showing no detectable proteolysis of polyhistidine 
tagged human pancreatic amylase. Casein served as a positive control.   
 
  
 
Fig. 4. Exposure to pancreatic amylase promotes biofilm formation. (A) Biofilm 
formation at 48 h by C. jejuni strains on glass tubes in the presence (black bars) or 
absence (white bars) of 100 nM HPA. Data reported as means and SD from three 
independent experiments. Asterisks indicate statistically significant increases in the 
presence of HPA; ***p<0.0001. (B) Biofilm formation at 48 h by C. jejuni 11168H on 
glass tubes in the presence (black bars) or absence (white bars) of 100 nM 
recombinant human amylase. Data reported as mean +/- SD from three independent 
experiments. Asterisks indicate statistically significant increases in the presence of 
pancreatic amylase; ***p<0.001. (C) Biofilm formation at 48 h by C. jejuni 11168H on 
glass tubes in the presence (black bars) or absence (white bars) of chicken pancreas 
extract. Data reported as mean +/- SD from three independent experiments. 
Asterisks indicate statistically significant increases in the presence of pancreatic 
without amylase with amylase
120
40
200
160
80
mm
A
C
0
0.05
0.1
0.15
0.2
0.25
0.3
O
D
6
0
0
B ***
O
D
6
0
0 ***
*** ***
***
***
***
D
0
0.05
0.1
0.15
0.2
0.25
0.3
11168H 81-176  kpsM waaC  waaF Cj0511 comp
0
0.05
0.1
0.15
0.2
0.25
0.3
O
D
 6
0
0
***
amylase; ***p<0.001. (D) CLSM of Live/Dead stained C. jejuni 11168H biofilm at 48 
h. Top panels, confocal images of bacteria in x-y plane, bottom panels, digital 
images in x-z plane. 
 
  
FIG. 5. Pre-exposure to pancreatic amylase promotes interaction with human 
intestinal epithelial cells. (A) Interaction with Caco-2 cells by C. jejuni 11168H 
grown in the presence (black bars) or absence (white bars) of 100 nM HPA. Bacteria 
were co-cultured with Caco-2 cells for 3, 6 and 24 h. (B) Invasion of Caco-2 cells by 
C. jejuni 11168H grown in the presence (black bars) or absence (white bars) of 100 
nM HPA. (C) Apical IL-8 levels in T84 cells at 24 h in response to C. jejuni 11168H, 
the Cj0511 mutant and the complemented strain grown in the presence (black bars) 
and absence (white bars) of 100 nM HPA. (D) Translocation of C. jejuni in T84 cells 
at 6 h. C. jejuni 11168H, a Cj0511 mutant and a complemented strain were grown in 
the presence (black bars) and absence (white bars) of 100 nM HPA. For (A) to (C), 
data reported as mean +/- SD from three independent experiments. For (D), data 
reported as mean +/- SD from three independent experiments for C. jejuni 11168H 
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and the cj0511 mutant. For the cj0511 complemented strain, the mean +/- SD from two 
independent experiments is reported as a result of contamination in the third experiment, 
thus no statistical analysis is presented. ***p<0.0001, *p<0.05. 
  
FIG. 6. Pre-exposure to pancreatic amylase promotes infection of Galleria 
mellonella larvae. Killing of G. mellonella larvae by C. jejuni grown in the presence 
(black bars) or absence (white bars) of 100 nM HPA. 10 larvae were infected with 
each strain or with PBS alone. Injection with PBS did not kill any larvae. The kpsM 
mutant and the cj0511 mutant and complemented strain were derived from C. jejuni 
11168H. Data reported as mean and SD from three independent experiments. 
Asterisks indicate statistically significant increases in the presence of HPA; 
**p=0.001. 
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FIG. 7. Pre-exposure to pancreatic amylase promotes colonisation of broiler 
chickens. (A) and (B) number of birds from which Campylobacter was isolated from 
the ileum at 4 d and 7 d post infection, respectively. C. jejuni was grown with (black 
bars) or without HPA (white bars). n=15 birds per group. By day 7, exposure of the 
WT strain to HPA prior to infection had a significant effect (p=0.005). (C) and (D) cfu 
of Campylobacter per gram of ileal contents in birds 4 d and 7d post infection, 
respectively. Open symbols show strains grown without HPA, closed symbols show 
strains grown with HPA. Bar indicates statistically significant difference. n=15 birds 
per group.   
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FIG. 8. Pre-exposure to pancreatic amylase promotes survival in stress 
environments. (A). Survival at 4°C of C. jejuni 11168H grown with (squares) or 
without (diamonds) HPA. (B). Survival at 20°C in air of C. jejuni 11168H grown with 
(squares) or without (diamonds) HPA. Data reported as means +/- SD from three 
independent experiments. Statistical significance between the counts in the 
presence and absence of HPA was assessed using a two-sample t-test, assuming 
unequal variance; **p<0.01, ***p<0.001. 
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